Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Mangoceuticals (MGRX) Gross Profit (2023 - 2025)

Mangoceuticals' Gross Profit history spans 3 years, with the latest figure at $50899.0 for Q3 2025.

  • For Q3 2025, Gross Profit fell 38.43% year-over-year to $50899.0; the TTM value through Sep 2025 reached $283014.0, down 36.03%, while the annual FY2024 figure was $379964.0, 11.94% down from the prior year.
  • Gross Profit for Q3 2025 was $50899.0 at Mangoceuticals, down from $89948.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $147398.0 in Q1 2024 and bottomed at $50899.0 in Q3 2025.
  • The 3-year median for Gross Profit is $82671.0 (2024), against an average of $92216.0.
  • The largest annual shift saw Gross Profit surged 157.69% in 2024 before it crashed 57.89% in 2025.
  • A 3-year view of Gross Profit shows it stood at $142583.0 in 2023, then plummeted by 43.82% to $80103.0 in 2024, then tumbled by 36.46% to $50899.0 in 2025.
  • Per Business Quant, the three most recent readings for MGRX's Gross Profit are $50899.0 (Q3 2025), $89948.0 (Q2 2025), and $62064.0 (Q1 2025).